Sunrest Lifescience (NSE:SUNREST) Other Current Liabilities: ₹29.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
41 GF Score
Price ₹35.00
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Other Current Liabilities?

Sunrest Lifescience NSE:SUNREST 41 Other Current Liabilities is ₹29.4 Mil as of Mar. 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review.

Sunrest Lifescience's other current liabilities for the quarter that ended in Mar. 2026 was ₹29.4 Mil.

Sunrest Lifescience's quarterly other current liabilities increased from Sep. 2024 (₹3.8 Mil) to Mar. 2025 (₹13.3 Mil) and increased from Mar. 2025 (₹13.3 Mil) to Mar. 2026 (₹29.4 Mil).

Sunrest Lifescience's annual other current liabilities increased from Mar. 2024 (₹9.0 Mil) to Mar. 2025 (₹13.3 Mil) and increased from Mar. 2025 (₹13.3 Mil) to Mar. 2026 (₹29.4 Mil).


Sunrest Lifescience Other Current Liabilities Related Terms


Sunrest Lifescience Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Other Current Liabilities Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial 7.51 13.81 8.97 13.25 29.41

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only 0.00 8.97 3.76 13.25 29.41
NSE:SUNREST
41GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹29.4 Mil mean?
Sunrest Lifescience (NSE:SUNREST) has a Other Current Liabilities of ₹29.4 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sunrest Lifescience.
Is Sunrest Lifescience's Other Current Liabilities too high?
Sunrest Lifescience's current Other Current Liabilities is ₹29.4 Mil. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Other Current Liabilities compare to competitors?
Sunrest Lifescience's Other Current Liabilities of ₹29.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Healthcare Providers & Services company?
A good Other Current Liabilities depends on the Healthcare Providers & Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sunrest Lifescience. Sunrest Lifescience's current Other Current Liabilities is ₹29.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Other Current Liabilities of ₹29.4 Mil. The current Other Current Liabilities is ₹29.4 Mil. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Other Current Liabilities is ₹29.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score

Get the complete analysis for NSE:SUNREST

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.00
Price